PSMA, also known as folate hydrolase I (FOLH1) and glutamate carboxypeptidase II (GCPII), is a 750-aminoacid type II transmembrane glycoprotein which is 1000-fold overexpressed on the surface of prostate cancer cells. Here, FOLH1 is linked to prostate cancer.